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Introduction
SPARC (secreted protein, acidic and rich in cysteine)/osteonectinIBM-40 is a secreted Ca 2 +binding glycoprotein of 43 kDa. 13 SPARC expression has been shown in some specific tumors such as breast,'l colorectaV esophagea1 6 cancers, melanoma, 7,~astrocytoma,~menin-gioma, 10 and hepatocellular carcinoma. II Ledda et al l2 reported that SPARC antisense RNA abrogates the tumorigenicity of human melanoma cells. Some reports have shown the relationship between SPARC and matrix metalloproteinase (MMP) secretions. For example, SPARC is co-expressed with stromelysin-3 in colorectal cancer, 5 and induces production of collagenase, stromelysin and gelatinase B,13,11 and mediates pro-gelatinase A activation via membrane type 1-MMP (MTl-MMP) . 15 In addition, it stimulates migration of human renal cell carcinorna 16 and prostatic cancer. 17 Thus, SPARC is thought to playa role of tumorigenesis and tumor progression.
We have previously reported that the expression of gelatinase B by high metastatic mouse B16 melanoma clones (FlO and BL6) is stimulated by acidic culture conditions.
IS ,19 As Martinez-Zaguilan et a1 20 pointed out, despite the acidity of tumors, most in vitro assays of tumor cell function are routinely performed at neutral-toalkaline medium pH. We therefore evaluated SPARC production in B16 melanoma clones cultured with neutral or acidic medium, and compared with their metastatic potentials in this study.
Materials and Metbods
Cell culture B16 variants (high metastatic BL6 and FlO and low metastatic F1) were used in this study. They were maintained in DME/F12 (Gibco/BRL, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS; Sera-Lab, Sussex, UK).
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Sub-confluent cultures were maintained in serum-free DME/FI2 with pH 5.9 or 7.3 for 3 days as described previously.IS In the case of BL6 cells, they were cultured in the serum-free media for 3 days in the presence or absence of 10 6 M BB-94 (British Biotech, Oxford, UK). CM was collected, concentrated by precipitation with ammonium sulfate at 80% saturation.
Zymography
Gelatinase B activity was measured by gelatin-zymography as reported previously. IS The proteins (10 )lg) in CM were electrophoresed on 10% polyacrylamide gels containing 0.1 % gelatin as the substrate. SDS was removed from the gels by washing with 2.5% Triton X-lOO. Enzyme reaction was carried out by incubating in the presence of 10 mM CaCl 2 at 3rC for 20 h. The resultant gels were stained with Coomassie Brilliant Blue R-250. .
SPARC proteins, secreted in neutral pH (7.3), were detected by Western blot as 3 bands (43-, 42-, 40-kDa) in the reducing conditions and 4 bands (40-, 36-, 35-, 30-kDa) in the non reducing conditions, respectively (Figure 1) . SPARC proteins were detected highly in BL6 and FlO, but faint in Fl cells. As previously reported elsewhere, IS the secretion of gelatinase B by FlO and BL6 cells was conSiderably stimulated by acidic culture medium (pH 5.9) (Figure 2a) . Their SPARC production remained identical with an identical pattern at pH 5.9 and 7.3 (Figure 2b) .
It has been reported that SPARC was degraded by several MMPs including gelatinase B. 21 Our results, however, did not show any significant degradation of SPARC at acidic pH, that would have been expected from gelatinase B overexpression. Moreover, the addition of BB-94, a synthetic MMP inhibitor, to the cultures did not affect SPARC electrophoretic mobility, suggesting that the several electrophoretic mobilities of SPARC bands could not be the consequence of proteolysis by MMPs (Figure 2b) . The fact KATO et al that activation of gelatinase B was not significantly caused by acidic culture conditions also might deny participated in MMPs for protein ladder of SPARC. The different bands of SPARC may correspond to different glycosylated forms rather than to different degradation products. As previous reports mentioned that SPARC induced MMP production or activation, we expected that increased gelatinase B production in acidic medium pH is caused by over expression of SPARC as an autocrine manner. However, the culture medium that was conditioned at pH 5.9 and then neutralized, and that is considered to be high SPARC content as shown in figure 2 , did not change gelatinase B production in FlO cells,'9 suggesting that production of SPARC and gelatinase B is regulated independently.
Rempel et al lO have found that invasive meningiomas produced excessive amount of SPARC independently of grade, and that the increased SPARC expression promoted glioblastoma in vitro invasion. SPARC also induced cell motility of renal cell carcinoma associated with type IV collagen. '6 In addition, SPARC production was well correlated with metastatic ability of mouse B16 melanoma cells in this study. Taken together, SPARC action might be a most effective in tumor intravasation or extravasation in the tumor metastasis process. The high expression of SPARC and gelatinase B particularly at acidic pH conditions therefore may independently support the metastatic behaviour of melanoma cells.
